MARKET WIRE NEWS
  1. Home
  2. Stock
  3. NRX:CC
  4. News
NRX:CC
Quote
Short
News
Articles
Message Board

NurExone Biologic Inc. (TSXVC : NRX:CC ) News

NurExone Biologic Inc. (TSXVC: NRX:CC) News Releases

NRX:CC News Releases
NRX:CC : TSXVC
GlobeNewswire
NurExone to Showcase Its Regenerative Medicine Platform at NANO.IL.2026 and Advanced Therapies Congress in March 2026 and Provides Corporate Update
NRX:CC : TSXVC
TMX Newsfile
NurExone Biologic Advances Manufacturing and Regulatory Roadmap with Independent Batch Consistency Results for Exosome Production
NRX:CC : TSXVC
GlobeNewswire
NurExone Appoints Eyal Gabbai to Board, Adding Large-Scale Healthcare System and Capital Markets Expertise
NRX:CC : TSXVC
Investing News Network
5 Best-performing Canadian Pharma Stocks (Updated January 2026)
NRX:CC : TSXVC
GlobeNewswire
NurExone Reports Anti-Inflammatory Activity of Its Exosomes in Lab Analysis
NRX:CC : TSXVC
GlobeNewswire
NurExone Plans Small-Scale of ExoPTEN Clinical Manufacturing in Preparation for FUTURE First in Human USE Pathways
NRX:CC : TSXVC
GlobeNewswire
NurExone Biologic Inc. Announces Third Quarter 2025 Financial Results and Provides Corporate Update
NRX:CC : TSXVC
Canadian Earnings Reports
Expected Canadian Company Earnings on Wednesday, November 26th, 2025
NRX:CC : TSXVC
GlobeNewswire
NurExone Secures over C$3.18 Million Through Accelerated Warrant Exercises
NRX:CC : TSXVC
Investing News Network
4 Best-performing Canadian Pharma Stocks of 2025

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.